Source: Clinical and translational medicine [Clin Transl Med] 2025 Mar; Vol. 15 (3), pp. e70251.Publisher: Wiley Country of Publication: United States NLM ID: 101597971 Publication Model: Print Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Editorial & Opinion

Impact of ALK inhibitors to potentiate ALK.CAR-T therapy in neuroblastoma.

Authors : Bergaggio E; Department of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Chiarle R

Subjects: Neuroblastoma*/Neuroblastoma*/Neuroblastoma*/drug therapy ; Anaplastic Lymphoma Kinase*/Anaplastic Lymphoma Kinase*/Anaplastic Lymphoma Kinase*/antagonists & inhibitors; Humans

Source: Clinical and translational medicine [Clin Transl Med] 2024 Jun; Vol. 14 (6), pp. e1732.Publisher: Wiley Country of Publication: United States NLM ID: 101597971 Publication Model: Print Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors Improve Renal Resistive Index in Patients With Type 2 Diabetes: A 26-Week Prospective Observational Real-Life Study.

Authors : Vozza A; Interdisciplinary Department of Medicine, School of Medicine, University of Bari 'Aldo Moro', Bari, Italy.; Volpe S

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use

Source: Journal of diabetes research [J Diabetes Res] 2025 Feb 10; Vol. 2025, pp. 8182211. Date of Electronic Publication: 2025 Feb 10 (Print Publication: 2025).Publisher: Wiley Country of Publication: United States NLM ID: 101605237 Publication Model: eCollection Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

USP7 inhibitors suppress tumour neoangiogenesis and promote synergy with immune checkpoint inhibitors by downregulating fibroblast VEGF.

Authors : Jurisic A; Almac Discovery Ltd., Health Science Building, Belfast, UK.; Sung PJ

Subjects: Neoplasms* ; Ubiquitin-Specific Peptidase 7*/Ubiquitin-Specific Peptidase 7*/Ubiquitin-Specific Peptidase 7*/antagonists & inhibitors ; Vascular Endothelial Growth Factor A*

Source: Clinical and translational medicine [Clin Transl Med] 2024 Apr; Vol. 14 (4), pp. e1648.Publisher: Wiley Country of Publication: United States NLM ID: 101597971 Publication Model: Print Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Integrative transcriptomic analysis identifies emetine as a promising candidate for overcoming acquired resistance to ALK inhibitors in lung cancer

Authors : Sang‐Min Park; Keeok Haam; Haejeong Heo

Subjects: acquired resistance; ALK inhibitors; connectivity map

Source: Molecular Oncology, Vol 19, Iss 4, Pp 1155-1169 (2025)

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Effects of sodium–glucose co‐transporter inhibitors on individual clinical endpoints and quality of life

Authors : Jia Liao; Yang Chen; Zhiyu Ling

Subjects: cardiovascular outcomes; heart failure (HF); myocardial infarction

Source: ESC Heart Failure, Vol 12, Iss 2, Pp 1271-1282 (2025)

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

The effects of sodium–glucose cotransporter 2 inhibitors on the ‘forgotten’ right ventricle

Authors : Liangzhen Qu; Xueting Duan; Han Chen

Subjects: pulmonary hypertension; right heart failure; right ventricular function

Source: ESC Heart Failure, Vol 12, Iss 2, Pp 1045-1058 (2025)

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Dynamic Change of PD-L2 on Circulating Plasma Extracellular Vesicles as a Predictor of Treatment Response in Melanoma Patients Receiving Anti-PD-1 Therapy.

Authors : Sun L; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Melanoma and Sarcoma, Peking University Cancer Hospital & Institute, Beijing, China.; Wei X

Subjects: Extracellular Vesicles*/Extracellular Vesicles*/Extracellular Vesicles*/metabolism ; Melanoma*/Melanoma*/Melanoma*/drug therapy ; Melanoma*/Melanoma*/Melanoma*/blood

Source: Journal of extracellular vesicles [J Extracell Vesicles] 2025 Apr; Vol. 14 (4), pp. e70054.Publisher: Wiley Country of Publication: United States NLM ID: 101610479 Publication Model: Print Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Assessments of prostate cancer cell functions highlight differences between a pan‐PI3K/mTOR inhibitor, gedatolisib, and single‐node inhibitors of the PI3K/AKT/mTOR pathway

Authors : Adrish Sen; Salmaan Khan; Stefano Rossetti

Subjects: gedatolisib; inhibitors; PI3K/AKT/mTOR pathway

Source: Molecular Oncology, Vol 19, Iss 1, Pp 225-247 (2025)

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

نتائج البحث

فلترة النتائج

Long-term effects of cholinesterase inhibitors and memantine on cognitive decline, cardiovascular events, and mortality in dementia with Lewy bodies: An up to 10-year follow-up study

BRAF V600E -PROTAC versus inhibitors in melanoma cells: Deep transcriptomic characterisation.

Impact of ALK inhibitors to potentiate ALK.CAR-T therapy in neuroblastoma.

Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors Improve Renal Resistive Index in Patients With Type 2 Diabetes: A 26-Week Prospective Observational Real-Life Study.

USP7 inhibitors suppress tumour neoangiogenesis and promote synergy with immune checkpoint inhibitors by downregulating fibroblast VEGF.

Integrative transcriptomic analysis identifies emetine as a promising candidate for overcoming acquired resistance to ALK inhibitors in lung cancer

Effects of sodium–glucose co‐transporter inhibitors on individual clinical endpoints and quality of life

The effects of sodium–glucose cotransporter 2 inhibitors on the ‘forgotten’ right ventricle

Dynamic Change of PD-L2 on Circulating Plasma Extracellular Vesicles as a Predictor of Treatment Response in Melanoma Patients Receiving Anti-PD-1 Therapy.

Assessments of prostate cancer cell functions highlight differences between a pan‐PI3K/mTOR inhibitor, gedatolisib, and single‐node inhibitors of the PI3K/AKT/mTOR pathway

اتصل بنا

اتبع